Cargando…
Cytoreductive nephrectomy in the age of immunotherapy-based combination treatment
Renal cell carcinoma (RCC) displays a wide spectrum of oncological prognosis and clinical behavior, and is noted for its generally poor outcome in metastatic settings. However, the introduction of immunotherapy after the cytokine era has changed the landscape of treatment for metastatic RCC, outperf...
Autores principales: | Song, Sang Hun, Lee, Sangchul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Urological Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10482658/ https://www.ncbi.nlm.nih.gov/pubmed/37668198 http://dx.doi.org/10.4111/icu.20230187 |
Ejemplares similares
-
New Paradigms for Cytoreductive Nephrectomy
por: Lichtbroun, Benjamin J., et al.
Publicado: (2022) -
Cytoreductive Nephrectomy and Nephrectomy/Complete Metastasectomy for Metastatic Renal Cancer
por: Russo, Paul, et al.
Publicado: (2007) -
Cytoreductive nephrectomy in the current treatment
algorithm
por: Kuusk, Teele, et al.
Publicado: (2019) -
Cytoreductive Nephrectomy in 2021: Obsolete
por: Meza, Luis, et al.
Publicado: (2021) -
Cytoreductive Nephrectomy in 2021: Obsolete but Necessary
por: Capitanio, Umberto, et al.
Publicado: (2021)